Functionalized carbon nanotubes as immunomodulator systems

Biomaterials

Volumn 34, Issue 18, 2013, Pages 4395-4403

  Pescatori, Mario ^a,b   Bedognetti, Davide ^c   Venturelli, Enrica ^d   Ménard Moyon, Cécilia ^d   Bernardini, Camilla ^e   Muresu, Elena ^f   Piana, Andrea ^f   Maida, Giorgio ^f   Manetti, Roberto ^f   Sgarrella, Francesco ^f   Bianco, Alberto ^d   Delogu, Lucia Gemma ^f  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Crosslinks BV   (Netherlands)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d CNRS   (France)

^e CATHOLIC UNIVERSITY   (Italy)

^f UNIVERSITY OF SASSARI   (Italy)

Author keywords

Carbon nanomaterials; Cytokines; Gene expression; Immune system; Microarrays; Nanomedicine

Indexed keywords

BIOMEDICAL APPLICATIONS; CARBON NANO-MATERIALS; CYTOKINES; FUNCTIONALIZED CARBON NANOTUBES; GENE EXPRESSION LEVELS; INFLAMMATORY PROCESS; MOLECULE INTERACTIONS; TUMOR NECROSIS FACTORS;

BODY FLUIDS; CELL CULTURE; CELLS; CHEMICAL ACTIVATION; IMMUNE SYSTEM; MEDICAL APPLICATIONS; MEDICAL NANOTECHNOLOGY; MICROARRAYS; MOLECULES; MULTIWALLED CARBON NANOTUBES (MWCN); POLYMERASE CHAIN REACTION; PROTEINS;

GENE EXPRESSION;

CARRIER PROTEIN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; CYTOKINE; ENZYME; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MEMBRANE RECEPTOR; MICRORNA; MULTI WALLED NANOTUBE; PROTEIN KINASE; RIBOSOME PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADAPTIVE IMMUNITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DENDRITIC CELL; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; INNATE IMMUNITY; LEUKEMIA CELL LINE; MICROARRAY ANALYSIS; MONOCYTE; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR REJECTION;

ADULT; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMANS; IMMUNOLOGIC FACTORS; JURKAT CELLS; MALE; MIDDLE AGED; MONOCYTES; NANOTUBES, CARBON; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 84875581095     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.02.052     Document Type: Article

References (54)

1. Ali-Boucetta H., Sainz R., Herrero M.A., Tian B., Prato M., Bianco A., et al. Asbestos-like pathogenicity of long carbon nanotubes alleviated by chemical functionalization. Angew Chem Int Ed 2013, 52:2274-2278.
2. Meng L., Zhang X., Lu Q., Fei Z., Dyson P.J. Single walled carbon nanotubes as drug delivery vehicles: targeting doxorubicin to tumors. Biomaterials 2012, 33:1689-1698.
3. Bonner J.C. Carbon nanotubes as delivery systems for respiratory disease: do the dangers outweigh the potential benefits?. Expert Rev Respir Med 2011, 5:779-787.
4. Villa C.H., Dao T., Ahearn I., Fehrenbacher N., Casey E., Rey D.A., et al. Single-walled carbon nanotubes deliver peptide antigen into dendritic cells and enhance IgG responses to tumor-associated antigens. ACS Nano 2011, 5:5300-5311.
5. Herrero M.A., Toma F.M., Al-Jamal K.T., Kostarelos K., Bianco A., Da Ros T., et al. Synthesis and characterization of a carbon nanotube-dendron series for efficient siRNA delivery. J Am Chem Soc 2009, 131:9843-9848.
6. Pantarotto D., Singh R., McCarthy D., Erhardt M., Briand J.P., Prato M., et al. Functionalized carbon nanotubes for plasmid DNA gene delivery. Angew Chem Int Ed Engl 2004, 43:5242-5246.
7. Fabbro C., Ali-Boucetta H., Da Ros T., Kostarelos K., Bianco A., Prato M. Targeting carbon nanotubes against cancer. Chem Commun (Camb) 2012, 48:3911-3926.
8. Bianco A., Kostarelos K., Prato M. Making carbon nanotubes biocompatible and biodegradable. Chem Commun (Camb) 2011, 47:10182-10188.
9. Ménard-Moyon C., Kostarelos K., Prato M., Bianco A. Functionalized carbon nanotubes for probing and modulating molecular functions. Chem Biol 2010, 17:107-115.
10. Delogu L.G., Magrini A., Bergamaschi A., Rosato N., Dawson M.I., Bottini N., et al. Conjugation of antisense oligonucleotides to PEGylated carbon nanotubes enables efficient knockdown of PTPN22 in T lymphocytes. Bioconjug Chem 2009, 20:427-431.
11. Fiorillo E., Orru V., Stanford S.M., Liu Y., Salek M., Rapini N., et al. Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue. J Biol Chem 2010, 285:26506-26518.
12. Burke A., Ding X., Singh R., Kraft R.A., Levi-Polyachenko N., Rylander M.N., et al. Long-term survival following a single treatment of kidney tumors with multiwalled carbon nanotubes and near-infrared radiation. Proc Natl Acad Sci U S A 2009, 106:12897-12902.
13. Cellot G., Cilia E., Cipollone S., Rancic V., Sucapane A., Giordani S., et al. Carbon nanotubes might improve neuronal performance by favouring electrical shortcuts. Nat Nanotechnol 2009, 4:126-133.
14. Delogu L.G., Vidili G., Venturelli E., Ménard-Moyon C., Zoroddu M.A., Pilo G., et al. Functionalized multiwalled carbon nanotubes as ultrasound contrast agents. Proc Natl Acad Sci U S A 2012, 109:16612-16617.
15. Yu Y., Zhang Q., Mu Q., Zhang B., Yan B. Exploring the immunotoxicity of carbon nanotubes. Nanoscale Res Lett 2008, 3:271-277.
16. Boraschi D., Costantino L., Italiani P. Interaction of nanoparticles with immunocompetent cells: nanosafety considerations. Nanomedicine (Lond) 2012, 7:121-131.
17. Jang J., Lim D.H., Choi I.H. The impact of nanomaterials in immune system. Immune Netw 2010, 10:85-91.
18. Boncel S., Muller K.H., Skepper J.N., Walczak K.Z., Koziol K.K. Tunable chemistry and morphology of multi-wall carbon nanotubes as a route to non-toxic, theranostic systems. Biomaterials 2011, 32:7677-7686.
19. Tahara Y., Nakamura M., Yang M., Zhang M., Iijima S., Yudasaka M. Lysosomal membrane destabilization induced by high accumulation of single-walled carbon nanohorns in murine macrophage RAW 264.7. Biomaterials 2012, 33:2762-2769.
20. Cheng C., Muller K.H., Koziol K.K., Skepper J.N., Midgley P.A., Welland M.E., et al. Toxicity and imaging of multi-walled carbon nanotubes in human macrophage cells. Biomaterials 2009, 30:4152-4160.
21. Dumortier H., Lacotte S., Pastorin G., Marega R., Wu W., Bonifazi D., et al. Functionalized carbon nanotubes are non-cytotoxic and preserve the functionality of primary immune cells. Nano Lett 2006, 6:1522-1528.
22. Delogu L.G., Venturelli E., Manetti R., Pinna G.A., Carru C., Madeddu R., et al. Ex vivo impact of functionalized carbon nanotubes on human immune cells. Nanomedicine (Lond) 2012, 7:231-243.
23. Kaur G., Valarmathi M.T., Potts J.D., Jabbari E., Sabo-Attwood T., Wang Q. Regulation of osteogenic differentiation of rat bone marrow stromal cells on 2D nanorod substrates. Biomaterials 2010, 31:1732-1741.
24. Chou C.C., Hsiao H.Y., Hong Q.S., Chen C.H., Peng Y.W., Chen H.W., et al. Single-walled carbon nanotubes can induce pulmonary injury in mouse model. Nano Lett 2008, 8:437-445.
25. Delogu L.G., Stanford S.M., Santelli E., Magrini A., Bergamaschi A., Motamedchaboki K., et al. Carbon nanotube-based nanocarriers: the importance of keeping it clean. J Nanosci Nanotechnol 2010, 10:5293-5301.
26. Pescatori M., Broccolini A., Minetti C., Bertini E., Bruno C., D'Amico A., et al. Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression. FASEB J 2007, 21:1210-1226.
27. Pan Q., Fouraschen S.M., Kaya F.S., Verstegen M.M., Pescatori M., Stubbs A.P., et al. Mobilization of hepatic mesenchymal stem cells from human liver grafts. Liver Transpl 2011, 17:596-609.
28. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
29. Simon R., Lam A., Li M.C., Ngan M., Menenzes S., Zhao Y. Analysis of gene expression data using BRB-ArrayTools. Cancer Inform 2007, 3:11-17.
30. Benjamini Y., Drai D., Elmer G., Kafkafi N., Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001, 125:279-284.
31. Bedognetti D., Balwit J.M., Wang E., Disis M.L., Britten C.M., Delogu L.G., et al. SITC/iSBTc cancer immunotherapy biomarkers resource document: online resources and useful tools - a compass in the land of biomarker discovery. J Transl Med 2011, 9:155.
32. Bedognetti D., Wang E., Sertoli M.R., Marincola F.M. Gene-expression profiling in vaccine therapy and immunotherapy for cancer. Expert Rev Vaccines 2010, 9:555-565.
33. DeForge L.E., Remick D.G. Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole blood. Biochem Biophys Res Commun 1991, 174:18-24.
34. Grinyo J., Vanrenterghem Y., Nashan B., Vincenti F., Ekberg H., Lindpaintner K., et al. Association of four DNA polymorphisms with acute rejection after kidney transplantation. Transpl Int 2008, 21:879-891.
35. Genomics Pennisi E. ENCODE project writes eulogy for junk DNA. Science 2012, 337(1159):61.
36. Alazzam A., Mfoumou E., Stiharu I., Kassab A., Darnel A., Yasmeen A., et al. Identification of deregulated genes by single wall carbon-nanotubes in human normal bronchial epithelial cells. Nanomedicine 2010, 6:563-569.
37. Ding L., Stilwell J., Zhang T., Elboudwarej O., Jiang H., Selegue J.P., et al. Molecular characterization of the cytotoxic mechanism of multiwall carbon nanotubes and nano-onions on human skin fibroblast. Nano Lett 2005, 5:2448-2464.
38. Spivey T.L., Uccellini L., Ascierto M.L., Zoppoli G., De Giorgi V., Delogu L.G., et al. Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis. J Transl Med 2011, 9:174.
39. Harris J.E., Fernandez-Vilaseca M., Elkington P.T., Horncastle D.E., Graeber M.B., Friedland J.S. IFNgamma synergizes with IL-1beta to up-regulate MMP-9 secretion in a cellular model of central nervous system tuberculosis. FASEB J 2007, 21:356-365.
40. Chang Y.J., Holtzman M.J., Chen C.C. Interferon-gamma-induced epithelial ICAM-1 expression and monocyte adhesion. Involvement of protein kinase C-dependent c-Src tyrosine kinase activation pathway. J Biol Chem 2002, 277:7118-7126.
41. Sanceau J., Wijdenes J., Revel M., Wietzerbin J. IL-6 and IL-6 receptor modulation by IFN-gamma and tumor necrosis factor-alpha in human monocytic cell line (THP-1). Priming effect of IFN-gamma. J Immunol 1991, 147:2630-2637.
42. Ikejima T., Okusawa S., Ghezzi P., van der Meer J.W., Dinarello C.A. Interleukin-1 induces tumor necrosis factor (TNF) in human peripheral blood mononuclear cells in vitro and a circulating TNF-like activity in rabbits. J Infect Dis 1990, 162:215-223.
43. Bonizzi G., Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004, 25:280-288.
44. Weiss G.R., Grosh W.W., Chianese-Bullock K.A., Zhao Y., Liu H., Slingluff C.L., et al. Molecular insights on the peripheral and intratumoral effects of systemic high-dose rIL-2 (aldesleukin) administration for the treatment of metastatic melanoma. Clin Cancer Res 2011, 17:7440-7450.
45. Carretero R., Wang E., Rodriguez A.I., Reinboth J., Ascierto M.L., Engle A.M., et al. Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes. Int J Cancer 2012, 131:387-395.
46. Ji R.R., Chasalow S.D., Wang L., Hamid O., Schmidt H., Cogswell J., et al. An immune-active tumor microenvironment favors clinical response to ipilimumab. Cancer Immunol Immunother 2012, 61:1019-1031.
47. Johnston H.J., Hutchison G.R., Christensen F.M., Peters S., Hankin S., Aschberger K., et al. A critical review of the biological mechanisms underlying the in vivo and in vitro toxicity of carbon nanotubes: the contribution of physico-chemical characteristics. Nanotoxicology 2010, 4:207-246.
48. Murphy F.A., Poland C.A., Duffin R., Al-Jamal K.T., Ali-Boucetta H., Nunes A., et al. Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. Am J Pathol 2011, 178:2587-2600.
49. Donaldson K., Murphy F.A., Duffin R., Poland C.A. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol 2010, 7:5.
50. Sohaebuddin S.K., Thevenot P.T., Baker D., Eaton J.W., Tang L. Nanomaterial cytotoxicity is composition, size, and cell type dependent. Part Fibre Toxicol 2010, 7:22.
51. Fenoglio I., Aldieri E., Gazzano E., Cesano F., Colonna M., Scarano D., et al. Thickness of multiwalled carbon nanotubes affects their lung toxicity. Chem Res Toxicol 2012, 25:74-82.
52. Wang X., Jia G., Wang H., Nie H., Yan L., Deng X.Y., et al. Diameter effects on cytotoxicity of multi-walled carbon nanotubes. J Nanosci Nanotechnol 2009, 9:3025-3033.
53. Oyewumi M.O., Kumar A., Cui Z. Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses. Expert Rev Vaccines 2010, 9:1095-1107.
54. Marrack P., McKee A.S., Munks M.W. Towards an understanding of the adjuvant action of aluminium. Nat Rev Immunol 2009, 9:287-293.